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Haematopoietic malignanciesleukaemia cell line (HSB-2) with HHV-6 led to the induction of exosome-like-
particles attached to newly formed HHV-6 enveloped particles and to ampliﬁcation of a 1642 bp molecule
consisting of a partial human endogenous retrovirus (HERV)-E polymerase gene and repetitive sequences.
We initiated an analysis of transcriptional patterns of predicted genes from HERV-E sequences in normal and
malignant haematopoietic cells. Transcription patterns of regions corresponding to gag, pol and env genes at
different chromosomal loci varied among cell types tested. Several speciﬁc transcripts were only observed in
malignant haematopoietic cells and transcriptional activity varied among different malignant cell types. A
transcript of 7.1 kb spanning the complete gag, pol and env gene region, originating from chromosome 8p23,
was identiﬁed in normal peripheral blood cells and cells of the chronic myeloid leukaemia cell line K562. Our
study describes new active HERV-E sequences and new loci throughout the human genome.
© 2008 Published by Elsevier Inc.IntroductionMost human endogenous retroviruses (HERVs) entered the human
genomemore than 10million years ago and represent approximately 8%
of the human genome (Bannert and Kurth, 2004). In the course of
evolution, long terminal repeat (LTR)-based homologous recombination
processes have resulted in retroelements either without or with LTR
regions. Solo-LTR retroelements occur frequently and resulted from
recombinational deletionsbetweenﬂanking LTRsof a full-length element
indicating recent integration events (Deininger et al., 2003; Hughes and
Cofﬁn, 2004; Belshaw et al., 2007). LTR-retroelements of HERV origin are
classiﬁed in at least 200 distinct families and subfamilies (Bannert and
Kurth, 2004; Deininger et al., 2003; Hughes and Cofﬁn, 2004; Belshaw et
al., 2007; Hughes and Cofﬁn, 2001). LTR-retrotransposons possess
transcriptional regulatory sequences located in the ﬂanking LTR,
functioning as alternative gene promoters (Medstrand et al., 2001;
Deininger and Batzer, 2002; Maksakova and Mager, 2005; Buzdin et al.,
2006; Dunn et al., 2006). Their transcription appears to be controlled by a
transposase-derived centromeric protein CENP-B (Cam et al., 2008).
Transcription of almost full-length HERV proviruses has been
described, located on different chromosomes (Mayer et al., 1999;
Tönjes et al., 1999; Kjellman et al., 1999). Even synthesis of retroviral
particles has been reported in teratocarcinoma cell lines (Löwer et al.,
1993; Bieda et al., 2001) and ancestral retrovirus genomes capable ofhausen@dkfz.de
mel@dkfz.de (R. Kimmel),
lsevier Inc.viral particle formation have been reconstructed (Jern et al., 2005)
regaining infectious properties (Dewannieux et al., 2006; Lee and
Bieniasz, 2007). The majority of the provirus copies are however non-
functional due to the accumulation of extensive deletions, duplications
and mutations in at least some of the open reading frames (Bannert
and Kurth, 2004; Deininger et al., 2003; Hughes and Cofﬁn, 2004;
Belshaw et al., 2007; Hughes and Cofﬁn, 2001). HERVs with a
functional env gene seem to be more active than HERVs without (Oja
et al., 2007). Expression of HERV-K env protein on the cell surface may
confer infectivity to simian immunodeﬁciency virus (SIV) (Dewan-
nieux et al., 2005). Splice products of this HERV-K gene are expressed
in transformed cells and have been reported to support proliferation
and tumor growth (Boese et al., 2000; Armbruester et al., 2002;
Oricchio et al., 2007). Syncytin of HERV-W acts as mediator of
trophoblast fusion during early pregnancy (Mameli et al., 2007).
A possible role for endogenous retroviruses in the pathogenesis of
human disease has been investigated in several previous studies (zur
Hausen, 2006). HERV transcripts have been demonstrated in normal,
benign- and malignant tissues and in cell lines of varying origin
(Medstrand et al., 1992; Wentzensen et al., 2007; Frank et al., 2008;
Wang-Johanning et al., 2007). Differences in the transcription of HERV-K,
HERV-H and HERV-E genes have been reported in normal peripheral
blood monocytes (PBMC), as well as in haematopoietic disease (Brodsky
et al., 1993; Armbruester et al., 2002; Lindeskog et al., 1998; Depil et al.,
2002; Patzke et al., 2002). Endogenous retrovirus transcription may be
transactivated byhumanherpesvirus infections. Epstein–Barr virus (EBV)
transactivates the HERV-K env genewhich seems to act as a superantigen
(Sutkowski et al., 2004; Hsiao et al., 2006), whereas HSV-1, HHV-6 or
varicella zoster virus (VZV) antigens stimulated endogenous retrovirus
38 B.K. Prusty et al. / Virology 382 (2008) 37–45reverse transcriptase activity in lymphocytes of patients with multiple
sclerosis (Brudek et al., 2007).
We observed the ampliﬁcation of a DNA fragment (1642 bp) in the
human T-cell leukaemia line HSB-2 after infection with HHV-6. This
fragment consists of a partial polymerase gene of a HERV-E-related
sequence ﬂanked by satellite DNA. This triggered our interest in a possible
involvement of HERV-E orHERV-E-related sequences (HERV-E-Related) in
leukemias and lymphomas.Geneampliﬁcation involving satelliteDNAhas
also been described in acute myeloid leukaemia (Streubel et al., 2000;
Fonatsch et al., 2001; Zatkova et al., 2004) and in bone-marrow
preparations (Lou et al., 1993), but the inclusion of endogenous retrovirus
sequences was not reported in these studies.
The HERV-E family of endogenous retroviruses has been described
to contain approximately 50 members (Taruscio et al., 2002).
Transcription of HERV-E env has been demonstrated in normal and
malignant tissues, as well as in autoimmune disease (Wang-Johanning
et al., 2007; Kitamura et al., 1994; Takeuchi et al., 1995; Yamura et al.,
1997; Shiroma et al., 2001; Bessis et al., 2004). Enhanced transcription
of HERV-E gag mRNA was also reported in systemic lupus erythema-
tosus patients (Ogasawara et al., 2001).
Here we report the search for novel HERV-E-related sequences in
the human genome data bank and the analysis of their transcriptional
activity in cells of human haematopoietic origin in comparison to
several other cell types. The results show that a larger numberofHERV-
ER sequences existwithin thehumangenome, sharing 90–93% identity
with the known full-length HERV-E sequences (AB062274 andFig. 1. HSB-2 cells were infected with HHV-6. Viral- and extracellular exosome-like-particle r
viral particles with exosome-like particles attaching to the HHV-6 envelope. (B) Rolling cir
molecule (1642 bp) only in HHV-6 infected HSB-2 cells and not in uninfected HSB-2 or L12
occurs within the 599 bp HERV-ER pol fragment (89% identity to part of the HERV-ER polymM10976). The HERV-ER gag, pol and env genes located on different
chromosomes are differentially transcribed depending on cell type.
The transcription of individual HERV-ER genes from different
chromosomes was demonstrated in haematopoietic cells, either only
in malignant or in both malignant and normal cells. A 7.1 kb transcript
of HERV-ER covering the gag, pol and env genes was obtained from
normal PBMC and from cells of the chronic myeloid leukaemia line
K562. Its corresponding DNA is located on human chromosome 8p23
in normal peripheral blood lymphocytes.
Differences in the transcriptional pattern of HERV-E and HERV-ER
sequences between malignant and non-malignant haematopoietic
cells raise questions concerning their role in growth regulation.
Results
Characterization of the ampliﬁed fragment in HSB-2/HHV-6 infected cells
Herpesviruses induce ampliﬁcation of other viral integrated or
episomal DNA sequences during their replication in cell culture as a
function of early viral genes (Schlehofer et al., 1983; Heilbronn and zur
Hausen, 1989). In an attempt to rescue potentially persisting DNA of
exogenous agents in cells of leukemic origin, we infected these cells
with human herpesvirus type 6. HHV-6 replicates in HSB-2 T-cell
leukaemia cells resulting in the production of abundant HHV-6 viral
particles. Electron-microscopic analyses of these cell cultures revealed
the presence of large quantities of extracellular exosome-like particlesesulted, as well as an ampliﬁed DNA molecule. (A) Electron-microscopic view of HHV-6
cle ampliﬁcation of total cellular DNA and EcoR1 digestion resulted in a distinct DNA
36 cells. (C) Schematic presentation of this 1642 bp molecule. The EcoR1 cleavage site
erase gene). Nt 600–1642 consists largely of repetitive satellite DNA.
Table 1
Primer sequences for all the primers used in RT-PCR
Primer name Primer sequence
(A) Short RT-PCR
HERV-ER—gag forward 5′ CCAGCTACCAGGAACTGACC 3′
HERV-ER—gag reverse 5′ TACATACGATAGCCCTCACA 3′
HERV-ER—pol forward 5′ TTA ACA CCC TGA ACC CCA CTA C 3′
HERV-ER—pol reverse 5′ TCC TTC CTC CAT CAC TTG TCC 3′
HERV-ER—env forward 5′ CCT GCA ACC ACC GTT TTT GA 3′
HERV-ER—env reverse 5′ GGG AGA GCG CTT GTG GAC TT 3′
GAPDH—forward 5′ TGG ATA TTG TTG CCA TCA ATG ACC 3′
GAPDH—reverse 5′ GAT GGC ATG GAC TGT GGT CAT G 3′
(B) Long RT-PCR
HERV-E-5′—gag forward 5′ CAAGGAAACACGGGTCAGACACAAG 3′
HERV-E-3′—env reverse 5′ TAT ACA CAG GGG AGC AGC AAG 3′
(C) For respective coding frames
Chr2.C1—forward (gag) 5′ TCC CTT TGA TCC CGT TAG CC 3′
Chr2.C1—reverse 5′ GCT GGG GGC ATT TGT TCT TC 3′
Chr2.C2—forward (pol) 5′ CAG GAT GAC AGT CGG GGG TA 3′
Chr2.C2—reverse 5′ AAG GGC AAG GGA CAG TCA GG 3′
Chr2.C3—forward (pol) 5′ CAT CAG ATT CGC CCC TGA GA 3′
Chr2.C3—reverse 5′ CAA AAC CCC GCA GCT CCT AA 3′
Chr2.C4—forward (pol) 5′ TGG GGC TAC CCA ATC TGA CA 3′
Chr2.C4—reverse 5′ CGA CAG GGC CCT CTG ATA CC 3′
Chr2.C5—forward (env) 5′ GGC AGG AAA CCC AAA TGA GG 3′
Chr2.C5—reverse 5′ TAC ACA GGG GAG CAG CAA GC 3′
Chr11.C1—forward (gag) 5′ GGC TGA GTT TGC AGG GAT GA 3′
Chr11.C1—reverse 5′ GCC AGG CTG AGT TTC CTT CC 3′
Chr11.C2—forward (pol) 5′ TTC TGC TTG CCT CGG ACT TG 3′
Chr11.C2—reverse 5′ GCA GGA GGG GAG TGT TCC AT 3′
Chr11.C3—forward (env) 5′ TCA TAC GGT TGC AGG CCA TC 3′
Chr11.C3—reverse 5′ CGT GTG CTG AAG TTT TCT GAT GAA 3′
Chr17.C1—forward (gag) 5′ CTG GGA ACC TAC CCC CAG TG 3′
Chr17.C1—reverse 5′ TGG GCC TGA CGT TCA TTC TC 3′
Chr17.C2—forward (pol) 5′ TAA TCG GAG CCA CGG GAG TT 3′
Chr17.C2—reverse 5′ CCG GCC TGT AGT CCT TGG TC 3′
Chr17.C3—forward (pol) 5′ CCC ACC GCT GTG AAG GTA GA 3′
Chr17.C3—reverse 5′ TGC TGT CCT ACC TCA GTG ACC TG 3′
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in HSB-2 cells, since most of the other cell lines used in this study are
either non-permissive for HHV-6 or did not permit sufﬁcient particle
production of HHV-6 to analyse this phenomenon. Total cellular DNA
from HHV-6-infected HSB-2 cultures repeatedly revealed a distinct
band after rolling-circle ampliﬁcation and EcoR1 restriction digestion
(Fig. 1B). This DNA was cloned and sequenced. Apart from rearranged
HHV-6 DNA sequences, we isolated a DNA molecule consisting of
1642 bp (HSB16.100, Acc. No. FM212574) containing 1043 bp of satellite
DNA and 599 bp sharing 89% identity with the polymerase gene of an
availableHERV-E-related sequence (Genbank accession nos. AF499232
and AY208746, nt3366–3958). The ﬁrst 67 amino acids of an open
reading frame (ORF) (123 amino acids, nt399–768) of HSB16.100
shared 69% similarity to part of theHERV-ER polymerase gene (Fig.1C).
The structure appeared to be circular with the EcoR1 cleavage site
within the polymerase region. The complete sequence of HSB16.100 is
located in chromosome 12p11.21. The presence of HERV-ER sequences
within this HSB16.100 amplicon stimulated the subsequent studies on
HERV-E and HERV-ER sequences in human leukemic and lymphoma
cell lines and their transcriptional activity within these cells.
Characterization of HERV-ER sequences in the human genome
Previous reports have deﬁned regions of the human genome on
which HERV-E sequences had been identiﬁed (Taruscio et al., 2002;
Renaudineau et al., 2005). We initially analysed database information
for the presence of the HERV-ER sequences which were ampliﬁed in
HSB-2 cells after HHV-6 infection. A full-length HERV-ER DNA
sequence (8.8 kb, Genbank accession no. AF499232) and its RNA
(8.4 kb, Genbank accession no. AY208746) was available and reported
to be isolated from blood cells of a patient with chronic myeloid
leukaemia. We failed to detect this complete sequence within the
human genome, but localized part of it on chromosome 2q37
(Genbank accession no. AC017104, 99% identity). It contained a
deletion of 670 bp in the pol region (RNaseH domain) and a minor
deletion of 19 bp within the integrase domain.
Our subsequent analyses of HERV-E- and HERV-ER-sequences in
the complete human genome deviate from the previously identiﬁed
loci of HERV-E sequences. In contrast to these previous reports,
chromosomes 6, 13 and 21 did not harbour any HERV-ER sequences
whereas they were however identiﬁed on chromosomes 9, 10, 14 andFig. 2. HERV-ER sequence locations on human chromosomes were determined by
databank analyses. Chromosome numbers are underlined. Hits — number of integrated
HERV-ER sequences. — HERV-ER sequence locations determined in the present
analyses differing from previously reported locations of HERV-E sequences. Chromo-
somes 6, 13 and 21 have been reported to harbour HERV-E sequences, but no HERV-ER
sequences could be located in the present study. Chromosomes 9, 10, 14 and 18 harbour
HERV-ER sequences, whereas previous reports did not locate any HERV-E sequences.18 (Fig. 2). Both HERV-E and HERV-ER sequences were located on all
other chromosomes except chromosome 15. Chromosomes 2q37,
8p23, 11q13 and 17q11.2 all revealed open reading frames, which
could code for gag, pol and env proteins. Transcription of the HERV-E
sequences on chromosome 17q11.2 could result in a full-length HERV-
E genome, whereas those located on 8p23 lack a 5′-LTR.
Transcription of HERV-ER gag, pol and env in human hematopoetic cells
A possible role for endogenous retroviruses in the pathogenesis of
haematological malignancies has been discussed earlier (zur Hausen,
2006). The ampliﬁcation of HERV-ER sequences in the leukemic cells
prompted us to investigate the transcription pattern of the individual
HERV-E and HERV-ER gag, pol and env genes in normal, as well as in
malignant human haematopoietic cells using RT-PCR and gene
speciﬁc primers (Table 1). We initially designed primers on the
available HERV-ER sequence (Genbank accession no. AY208746).
Equal amounts of cDNA, representing the total RNA extracts from
each cell type, were ampliﬁed with the respective primers. All
amplicons were cloned and sequenced.
HERV-ER gag was transcribed in all cells analysed, including
normal as well as malignant cells (Fig. 3), although the HERV-ER
gag amplicon was only faintly visible in HSB-2 cells. HERV-ER env
and pol transcripts were also observed in all cells tested. Analysis
of the resulting sequence data indicated varying identity of the
ampliﬁed sequences with HERV-ER (b95%). The majority of the
initial sequences obtained could be assigned to chromosomes
11q13 and 17q11.2. Chromosomes 2q37 (GenBank accession no.
AC017104), 11q13 (GenBank accession no. AP003498) and 17q11.2
(GenBank accession no. AB062274) all harbour ORFs representing
Fig. 3. HERV-ER gag, pol and env gene transcripts were ampliﬁed by RT-PCR using primers designed on the HERV-ER sequence (GenBank accession no. AY208746). Total cellular RNA
from PBMC preparations of 4 healthy blood donors and 6 malignant hematopoietic cell lines were ampliﬁed. Non-reverse transcribed RNA preparations were included. GAPDH
ampliﬁcation was used as an internal control and placental DNA (100 ng) as positive control ampliﬁcation. Arrows indicate the positions of ampliﬁed products and their respective
sizes.
40 B.K. Prusty et al. / Virology 382 (2008) 37–45partial pol, env and gag genes. We continued to investigate the
HERV-ER gene speciﬁc transcription using primers designed on
these ORFs (Fig. 4A and Table 1).Fig. 4. HERV-ER transcripts were localized to the predicted coding frames of HERV-ER and
predicted HERV-ER and HERV-E ORFs on the chromosomes 2q37 (GenBank accession no. AC
AB062274). Primers designed for RT-PCR ampliﬁcation of the respective coding frames are in
with the respective partial genes and amplicon sizes are indicated. GAPDH ampliﬁcation isAmpliﬁcation of the respective regions varied between samples.
Primers for coding frames 2 (pol region) and 5 (env region) on
chromosome 2q37 ampliﬁed transcripts from almost all samples,HERV-E sequences on chromosomes 2, 11 and 17. (A) Schematic presentation of the
017104), 11q13 (GenBank accession no. AP003498) and 17q11.2 (GenBank accession no.
dicated by arrowheads. (B) Gel electrophoresis of the ampliﬁed products. Coding frames
used as an internal control and placental DNA ampliﬁcation as positive control.
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frames 3 and 4) could not be ampliﬁed in several samples (Fig. 4B).
Similarly, almost all samples were ampliﬁed with primers from the
chromosome 11q13 coding frames 1 (gag) and 3 (env), whereas only
haematopoietic cell samples ampliﬁed with primers locating to codon
2 (pol). Primers on the env region of chromosome 17q11.2, similar to
chromosome 2q37, ampliﬁed transcripts in all samples tested.
Subsequent sequence analyses of the cloned amplicons indicated
however that the transcripts originated fromHERV-ER regions located
on a range of different chromosomes (Table 2). The nucleotide identity
between these sequences ranged from 85 to 95%. Transcripts aligned
to all 3 HERV-ER gag, pol and env regions on chromosomes 2q37, 8p23
(GenBank accession no. AC087342), 11q13, 17q11.2 and chromosome
20p11.2 (GenBank accession no. AL035661). HERV-ER transcripts
originating from other chromosomes, included combinations of 2 or a
single HERV-ER gene as indicated in Table 2. Interestingly, the data
pointed to cell type speciﬁcity for some of the transcripts, i.e. certain
transcripts were demonstrated in any malignant cell line tested, a
numberwas restricted to malignant hematopoietic cells only, whereas
others were present in both normal and malignant cells. The HERV-ERTable 2
HERV-E and HERV-ER ORFs on different chromosomes are transcribed either only in
malignant or malignant hematopoietic or normal and hematopoietic cells
Dark grey — malignant hematopoietic cells.
Light grey — normal and hematopoietic cells.gag, pol, and env regions on chromosome 17q11.2 were transcribed
only in malignant cells (haematopoietic origin and SiHa cervical
carcinoma). Theminor sequence divergence found in an env transcript
(sequence CHR2.5.8, chromosome 17q11.2-related) in normal kerati-
nocytes (HFK) (Fig. 5B) results in single amino acid differences in the
predicted polypeptide. This variation may reﬂect structural differ-
ences, which in turn could have functional relevance.
HERV-ER genes transcribed only in malignant haematopoietic cells
were pol locating to chromosomes 2p13, 3p26, 4p16, 10p13 and
17q11.2, gag on chromosomes 7p22, 9q34, 13q14, 19p12 and 20p11.2
and env on chromosomes 3p26, 3q21, 11p15 and 12p12. Haemato-
poietic cell speciﬁc transcription (i.e. including healthy PBMC) of
HERV-ER pol resulted from chromosomes 2q37, 3q21 and 12p13, of
gag from chromosome 4q31.2 and of env from chromosome 8p23
and 12p13. Overlapping amino acid sequences for HERV-ER gag and
env regions, obtained from the transcripts localizing to the respective
chromosomes, were analysed (Figs. 5A and B). A remarkable similarity
was noted between HERV-ER env sequences from these different loci,
although a few alternative amino acids may indicate structural and
functional differences. A larger amino acid divergence was evident in
the gag regions, whereas the wide sequence variation in the pol region
did not allow for any informative amino acid alignment.
Larger HERV-ER transcripts were subsequently generated with 5′-
and 3′-RACE-PCR. The high-rate of sequence homology between
different chromosomal loci hampered our attempts to obtain full-
length 5′ and 3′ transcripts from all samples. Two transcripts her32
(2278 bp) (accession no. FM212575) and her38 (2364 bp) (acc no.
FM212572) were obtained by 3′-RACE-PCR from the K562 cell line.
Each of these transcripts consisted of the entire env region and the 3′-
LTR. The her38 transcript shares 99% nucleotide identity with the
HERV-E referral sequence on chromosome 17q11.2, whereas her32
(2278 bp) shared 99% nucleotide identity to the HERV-ER sequences
on chromosome 11q13. Possible protein expression from these HERV-
E and HERV-ER sequences will be investigated in future studies.
Identiﬁcation of larger transcripts of HERV-ER
Subsequent attempts to amplify full-length genomic transcripts
including the LTRs failed. Ampliﬁcation of a HERV-ER transcript
spanning the region between gag (HERV-E.5′gag—forward) and env
(HERV-E.3′env—reverse) however generated a 7.1 kb transcript from 5
PBMC samples and K562 cells (Fig. 6). An additional, slightly larger
transcript, ampliﬁed in one PBMC sample and in K562 cells, could not
be cloned. Sequence analysis of the cloned 7118 bp HERV-ER transcript
(accession no. FM212573) revealed that it originated (99% identity)
from chromosome 8p23 (GenBank accession no. AC130352) and
harboured all three predicted genes (gag, pol and env). It shared 92%
identity with the HERV-E sequence on chromosome 17q11.2. Its
overlapping region (nt5496–7118) with her32 (nt1–1628) shared 96%
identity. Subsequent attempts to amplify similar transcripts from
other malignant haematopoietic cell lines of B- or T-cell origin, as well
as from HeLa or SiHa (both represent cervical cancer cell lines) and
H1299 (lung cancer cell line) failed. T- and B-cells were isolated from
total PBMCs and controlled for purity by RT-PCR for CD3 (speciﬁc for T-
cells) and CD20 (speciﬁc for B-cells) (data not shown). The 7118 bp
transcript was again ampliﬁed from both T- and B-cells with long
range RT-PCR (data not shown).Discussion
The disease-associated relevance of endogenous retroviruses has
been controversial. Expression of HERV genes has been demon-
strated in both normal and diseased tissue (Bannert and Kurth,
2004). A model estimating endogenous retrovirus activity suggests
7% of all HERV sequences to be active (Oja et al., 2007). An
Fig. 5. Amino acid sequences of overlapping partial HERV-E and HERV-E gag and env regions were aligned. Sequences obtained after ampliﬁcation with primers on coding frames of
chromosomes 2, 11 and 17 are indicated on the right and overlapping regions indicated in dark grey. Human chromosomal sequences are given in italics. The closest sequence
similarity and cell lines of origin are indicated on the left. Amino acids, which may result in structural and functional modiﬁcations of the predicted proteins are boxed and indicated
by ⁎. (A) Partial gag genes and (B) partial env genes.
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has also frequently been addressed. HERV-K expression supports cell
transformation (Boese et al., 2000; Oricchio et al., 2007) and the
expression of its gag and env genes are higher in leukaemia cells
than in normal PBMC (Depil et al., 2002). HERV-E transcription has
been demonstrated in ovarian cancer (Wang-Johanning et al., 2007)
and rheumatoid arthritis (Takeuchi et al., 1995) and its LTR serves as
promoter for several cellular genes (Medstrand et al., 2001; Schulte
et al., 2000; Landry et al., 2002 and Landry and Mager, 2003). HERV-
E expression has often been reported in PBMC of healthy individuals
(Medstrand et al., 2001; Lindeskog et al., 1998). Our demonstration
of an ampliﬁed DNA molecule (1642 bp) resulting after HHV-6
infection of HSB-2 cells, led us to search for similar sequences in the
human genome and to investigate whether HERV-ER transcription
in malignant cells differed from that in normal cells. Our genome-
wide screening indicated that HERV-ER sequences are located on
the majority of human chromosomes, although their locations seemto vary somewhat from those previously described for HERV-E
sequences (Taruscio et al., 2002; Renaudineau et al., 2005). The total
number of HERV-E and HERV-ER sequences (211 hits, Fig. 2)
substantially exceeds the previous estimate of 50 members (Taruscio
et al., 2002).
In the course of evolution large numbers ofmutations accumulated
within most of the HERV genes resulting in the disruption of their
open reading frames. In some instances, however, mainly env regions
preserved larger open reading frames. This accounts for example for
env regions in speciﬁc HERV-H (Lindeskog et al., 1999), HERV-W
(Blond et al., 1999) and HERV-R (Cohen et al., 1985) genomes. In this
study, we ampliﬁed and cloned different transcripts of HERV-E and
HERV-ER gag, pol and env regions. The corresponding chromosomal
loci of these transcripts are listed in Table 2. The analysis was
restricted to cell lines of haematopoietic origin derived from various
malignant proliferations (T-cell leukaemias, chronic myeloid leukae-
mia, Hodgkin's disease) and to peripheral blood cells. Several
Fig. 6. Long-range RT-PCR ampliﬁcation of HERV-ER of transcripts. The 7.1 kb HERV-ER
transcript (arrow) was ampliﬁed in cDNA from 3 samples of normal hematopoietic cells
as well as in K562 cells, but not in placenta HeLa and HSB-2 cells. The slightly larger
transcript present in one PBMC preparation and in K562 cells, could not be cloned.
GAPDH ampliﬁcation is used as an internal control.
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keratinocytes were included as controls. In this initial study the
selection of cell lines instead of primary tissues from the respective
patient group was driven by the expectation that these lines are
composed of relatively homogeneous populations of tumour cells,
thus avoiding the inevitable contamination with normal cells in
biopsy tissue.
The transcription pattern of HERV-ER sequences was remarkably
heterogeneous between the different groups of cells analyzed:
selective transcription for malignant and non-malignant haemato-
poietic cells was observed for the gag gene region at chromosomal
location 4q31.2, in the pol region at chromosomes 2q37, 3q21 and
12p13 and for the env region at location 8p23 and 12p13. Interestingly,
transcription of HERV-E and HERV-ER regions in malignant haema-
topoietic cells only was observed in the gag regions at 7p22, 9q34,
13q14, 19p12 and 20p11.2, the pol region at 2p13, 3p26, 4p16, 10p13
and 17q11.2 and the env region at 3p26, 3q21, 11p15 and 12p12.
Computer analysis of four HERV-E and HERV-ER chromosomal
loci on chromosomes 2q37, 8p23, 11q13 and 17q11.2 revealed open
reading frames which could code for intact gag, pol and env
proteins. Particularly noteworthy is the HERV-E sequence on
chromosome 17q11.2. It maintains open reading frames that can
code for an intact full-length retroviral genome of approximately
8 kb and represent the referral HERV-E sequence. This transcript,
however, was not found in our study. Shiroma et al. (2001) have
shown the expression of transcripts of 3.3 kb and 4.1 kb from the
same location in pancreas and thyroid tissues. By using 3′-RACE
technology, we could clone a 2.4 kb transcript (her38) from K562
cells containing the complete env gene and 3′-LTR from this locus.
We cloned a similar transcript of 2.3 kb from chromosome 11q13
with 93% sequence identity to HERV-E. Conservation of an open
reading frame could suggest a biological function, as shown for
syncytin, a HERV-W env-derived protein in placental tissue. In
addition, the expression of retroviral env protein has been shown
to confer infectivity to related exogenous retroviruses (Dewannieux
et al., 2005).Another potentially important HERV-ER sequence at chromosome
2q37might play a role in tumorigenesis: it is located just 1000 bp away
at the 3′ end of β-Gal β-1,3-N-acetylglucosaminyltransferase 7
(B3GNT7), a putative tumor promoter (Kataoka and Huh, 2002). One
of the previously described cDNA clones (GenBank accession no.
AK126207),which is homologous to B3GNT7, includes the 5′-LTRof this
HERV-ER at 2q37. It has been speculated that transcription initiation
from HERVs into neighbouring genes in anti-sense orientation might
interfere with cellular gene expression (Villesen et al., 2004).
The genome coding potential of HERV-ER sequences at three
different chromosomal loci was further analyzed. By designing
primers at extreme ends, we could amplify by long RT-PCR and
clone transcripts of 7.1 kb from chromosome 8 (8p23) from 3 normal
PBMC samples and from K562 cells (Fig. 6). All the normal blood
samples contained transcripts of similar size. In one normal blood
sample, however, two transcripts occurred, differing by few hundred
base pairs (Fig. 6). Similar ampliﬁcation of two bandswas also found in
K562 cells. This larger transcript was not identiﬁed in the other
malignant haematopoietic cells studied. Attempts to obtain the
complete sequences of the 5′- and 3′-end of this transcript by RACE-
PCR were unsuccessful because of high sequence homology (above
90%) of this HERV-ER to other HERV-ER sequences. Analysis of the
chromosomal locus 8p23 revealed that this HERV-ER is devoid of a 5′-
LTR. We were unable to amplify a larger transcript at 8p23 by using a
reverse primer located on the 3′-LTR. This seems to argue against a
complete retroviral transcript at this location. As this transcript was
observed mostly in normal blood cells, it could suggest its possible
role in normal cell physiology.
The presented data show that the HERV-E subfamily of
endogenous retroviruses is substantially larger than previously
reported. The transcriptional pattern of individual HERV-E and
HERV-ER sequences differs between cells derived from cell lines of
haematopoietic origin, normal peripheral blood mononuclear cells
and several epithelial cells tested in this study. Yet, some common
transcripts exist in all cell types tested, some are selectively found in
haematopoietic cells and ﬁnally an interesting group of transcripts
was thus far found only in malignant haematopoietic cells. Future
studies should analyse the RNA transcription and expression of
HERV-E proteins in preparations derived from leukemic blood and
other hematopoetic malignancies.
Materials and methods
Cell culture and primary lymphocytes
Human malignant haematopoetic cell lines K562 (chronic
myeloid leukaemia), Jurkat, HSB-2 and Molt-3 (human T-cell
leukaemias), L428 and L1236 (Hodgkin's lymphoma) were main-
tained in RPMI1640 (containing 10% heat-inactivated fetal calf
serum, 100 U/ml penicillin and 100 μg/ml streptomycin) in a
humidiﬁed incubator at 37 °C and 5% CO2. The human epithelial
line HaCaT, primary human foreskin keratinocytes (HFK) and the
lung cancer cell line H1299, and the cervical carcinoma cell lines
HeLa and SiHa were maintained in modiﬁed DMEM containing 10%
heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 μg/ml
streptomycin. Peripheral blood mononuclear cells (PBMCs) were
isolated from heparinized venous blood of 5 different normal
healthy blood donors by gradient centrifugation using HISTOPA-
QUE®-1077 (Sigma, USA).
Puriﬁcation of the ampliﬁed fragment from HSB-2/HHV-6 infected cells
HSB-2 cells were infected with a stock culture of HSB-2/HHV-6
supernatant and harvested at 5 days post-infection. Total cellular
DNA was extracted with phenol–chloroform and precipitated with
ethanol. DNA was subjected to rolling-circle ampliﬁcation with a
44 B.K. Prusty et al. / Virology 382 (2008) 37–45TempliPhi Kit (GE Healthcare). Ampliﬁed DNA was digested with
the restriction enzyme EcoR1 prior to separation by gel electro-
phoresis. The ampliﬁed fragment was eluted from the gel with a
gel extraction spin kit (Genomed) and cloned into the vector pUC19
prior to sequencing.
Electron microscopy
Preparation of cells for electron-microscopic analysis has been
described before (Leppik et al., 2007).
Semi-quantitative reverse transcriptase-PCR (RT-PCR)
Total cellular RNA was extracted from PBMCs and from cultured
cells using the single-step acid guanidinium thiocyanate phenol–
chloroform extraction method (Chomczynski and Sacchi, 1987). Long
transcripts of HERV-ER were obtained in a single tube semi-
quantitative reverse transcriptase-PCR (RT-PCR) ampliﬁcation using
the RNA LA Takara PCR kit (Takara Biosciences) and following the
manufacturer's protocol. Brieﬂy, ﬁrst-strand cDNA synthesis was
performed on total cellular RNA (1 μg) at 42 °C for 1 h in a reaction
mixture in a total volume of 10 μl and containing 0.125 U AMV
Reverse TranscriptaseXL, 2.5 mM of random hexamers, 5 mM MgCl2
and 0.25 U RNase inhibitor. All RNA samples were subjected to
strong DNase treatment prior to reverse-transcription reactions.
Each RNA sample was also controlled for DNA contamination by
performing RT-PCR in the absence of reverse transcriptase. The total
cDNA product was subjected to PCR ampliﬁcation using primers to
amplify gag, pol and env genes (summarized in Table 1). Long PCR
ampliﬁcation (N1 kb amplimer) was performed as follows: an initial
cycle of denaturation at 92 °C for 2 min was followed by 10 cycles of
denaturation at 92 °C for 10 s, primer annealing at 64 °C for 30 s
and primer extension at 68 °C for 6 min, followed by 20 additional
cycles under similar conditions except that the primer extension
time was increased for 20 s per subsequent cycle. PCR was
terminated with a ﬁnal extension step for 10 min at 72 °C. The
temperature proﬁle used for the PCR ampliﬁcations of smaller
fragments (b1 kb) is as follows: initial denaturation at 95 °C for
3 min, denaturation at 94 °C for 1 min, primer annealing at 64 °C for
1 min, primer extension at 72 °C for 1 min, ﬁnal extension of 72 °C
5 min. Ampliﬁed products were gel puriﬁed (JETquick Gel extraction
kit, GENOMED, Germany) and cloned into the pCR2.1 TA cloning
vector (Invitrogen, Carlsbad, CA). Resulting clones were sequenced
using standard techniques. Both strands of three clones per
amplicon were sequenced. 5′- and 3′-ends of the transcripts were
determined by using RACE (Rapid Ampliﬁcation of cDNA Ends)
according to the manufacturer's protocol (BD Smart™ RACE cDNA
Ampliﬁcation Kit, Clontech, USA).
Sequence analysis
Obtained sequences were analysed for established homologies
using nblast and megablast programs (http://www.ncbi.nlm.nih.gov/
blast/) searching in standard non-redundant databases, as well as in
high throughput genomic sequences database (human genomic plus
transcript). Deduced amino acid sequence similarity was analyzed
using the translated BLAST search (BLASTX). The predicted open
reading frames were generated from the splice variant sequences
using the Frames software from the HUSAR program package
(Senger et al., 1998).
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